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Abstract  
AIM: This study aimed to evaluate the cardiac autonomic dysfunction and the cardiac arrhythmia risk using heart 
rate variability parameters in subjects with vitamin D deficiency and low cardiovascular risk.  
MATERIAL AND METHODS: One hundred five consecutive individuals, 54 patients with low vitamin D status and 
51 healthy controls were enrolled in this study. The overall cardiac autonomic tone was quantified by using 
various heart rate variability parameters included mean RR interval, mean Heart Rate, mean of standard 
deviations of intervals for 24 hours (SDNN), standard deviation of averages of intervals (SDANN), mean of 
standard deviation of intervals for 5 minutes (SDNNI), root mean square of difference of successive intervals 
(rMSSD) and the proportion of intervals differing more than 50 ms (pNN50) values. The 12-lead ECG was 
recorded from each participant, and QT intervals were measured. 
 
RESULTS: Baseline demographic profiles were similar between two groups. The heart rate variability parameters 
such as mean RR interval, mean HR, SDNN, SDANN, SDNNI, rMSSD and pNN50 (%) values were not 
significantly different in patients with low vitamin D status compared to control group. The electrocardiography 
analysis revealed only slight but significant prolongation of corrected QT (QTc) intervals in the control group.  
CONCLUSION: HRV variables were not significantly altered in patients with vitamin D deficiency in low 
cardiovascular risk profile group. Further studies evaluating these findings in other cohorts with high 
cardiovascular risk are required. 
 
 
Introduction 
 
Vitamin D has a major role in a wide range of 
systems and organ functions including the 
cardiovascular system, beyond its effects on bone [1, 
2]. The prevalence of vitamin D deficiency is high in up 
to 50% of healthy adults [3]. Vitamin D deficiency has 
been implicated in a variety of cardiovascular 
disorders, including hypertension, coronary artery 
disease, heart failure, and peripheral vascular disease 
[4, 5]. The experimental studies have shown the 
potential link between low vitamin D levels and the 
activation of the renin-angiotensin system, 
inflammation, peripheral insulin resistance, endothelial 
dysfunction, and adverse ventricular remodelling [6-
10]. Recent studies revealed that vitamin D deficiency 
results in structural and ionic channel remodelling and 
autonomic dysfunction that may predispose the 
individuals to lethal cardiac arrhythmias and sudden 
cardiac death (SCD) [11-15]. 
Heart rate variability (HRV), the variation in the 
cardiac interbeat interval over time, provides a non-
invasive assessment of cardiovascular autonomic 
functions [16]. It has been used as a predictor of 
sudden cardiac death or a marker of the progression 
of cardiovascular disease in several high-risk 
populations [17, 18]. 
There has been only one study evaluating the 
effects of the vitamin D deficiency on HRV with 
confusing results. In this study, we aimed to evaluate 
the cardiac autonomic dysfunction using HRV 
parameters and in-patient with low cardiovascular risk 
and vitamin D deficiency [19]. 
 
 
Material and Methods 
 
A total 105 subjects, 54 patients with vitamin D 
deficiency and 51 healthy controls were enrolled in this 
study. All subjects were free of cardiovascular risk 
factors and haed been living in a city of western 
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Anatolia all through their life. Exclusion criteria were as 
follows: hypertension, diabetes mellitus, thyroid 
disorders, coronary artery disease, valvular heart 
disease; left ventricular dysfunction, use medications 
that interfere with vitamin D metabolism, primary 
hyperparathyroidism, hypercalciuria, malignancy, 
sarcoidosis, Paget's disease, malabsorption 
syndromes, estimated glomerular filtration rate ≤ 60 
ml/min, and history of nephrolithiasis.  
All subjects were recruited from Sakarya 
University School of Medicine (SAU) between October 
2011 and September 2012. All the procedures were 
hby the ethical standards of the responsible committee 
on human experimentation (institutional or regional) 
and with the Helsinki Declaration of 1975, which was 
revised in 1983. The Ethics Committee of Sakarya 
University Faculty of Medicine approved the study 
protocol. 
 
Biochemical Examination 
For blood tests, subjects were asked to fast for 
at least 12 h, and the blood was centrifuged at 3,000 
rpm for 15 min to obtain the serum. Serum 25(OH) D 
was analysed using 25 OH Vitamin D reagent based 
on the enzyme immunoassay (IDS Ltd. Boldon UK). 
 
Electrocardiography and Holter analysis 
The 12-lead electrocardiograms (ECG) were 
recorded from each participant with sinus rhythm (25 
mm/s rate and 1 cm/mV amplitude). 
Electrocardiograms were transferred to a personal 
computer via a scanner, magnified by Adobe 
Photoshop software, and then the duration of QT and 
RR intervals were measured. QT interval, which is the 
duration from the beginning of QRS complex to the 
end of T wave, was measured in a derivation in which 
T wave was clearly seen. Measured QT intervals were 
corrected by Bazett’s Formula (QT/ √RR), and defined 
as corrected QT interval (QTc). 
All subjects underwent 1- hour Holter 
monitoring while they were in a sitting position after 
resting for 30 minutes for HRV analyses. The 
measurements were taken in the morning times by 
single investigator blinded to the diagnosis of the 
participants. Holter ECGs were analysed using the Del 
Mar Reynolds Pathfinder Holter system. The time-
domain parameters were calculated: mean of all 
normal RR intervals (mean RR); standard deviations of 
all normal-to-normal (NN) intervals, (SDNN); mean of 
the standard deviations of all NN intervals for all 5- 
minute segments of the entire recording (SDNNI); 
standard deviation of the averages of NN intervals in 
all 5-minute segments of the entire recording 
(SDANN); the square root of the mean of the sum of 
the squares of differences between adjacent NN 
intervals (rMSSD); the number of pairs of adjacent NN 
RR intervals differing by more than 50 ms divided by 
the total number of all NN intervals (pNN50 total). EKG 
exclusion criteria were as follows: atrial fibrillation, 
recordings with non-sinus beats that were more than 
1% of a total number of beats, and artefacts. 
 
Statistical Analysis 
Statistical analysis was performed using the 
Statistical Package for Social Sciences (SPSS, 
Chicago, IL, USA), version 15.0 software for Windows. 
Descriptive statistics (frequency, mean, standard 
deviation, ranges) were calculated. The quantitative 
values between two groups were compared using a t-
test, and the qualitative values were compared using 
the 2 test. Correlation of variables was demonstrated 
using Pearson's and Spearman's correlation 
coefficients in normal distributed parametric and 
nonparametric variables, respectively. For assessment 
of the association of variables, linear regression and 
logistic regression were used for parametric and binary 
variables, respectively. P value of <0.05 was 
considered as statistically significant in all cases. 
 
 
Results 
 
Fifty-four (7 male, 47 female) individuals with 
vitamin D deficiency and 51 healthy subjects (14 male, 
37 female) were included this study. Age, sex, systolic 
blood pressure, diastolic blood pressure, mean heart 
rate, body mass index were not significantly different 
between two groups. Serum values of 25(OH) D, 
calcium, parathormone, creatinine, TSH, FT4 and 
glucose were not different between the two groups 
(Table 1). 
Table 1: Baseline Demographic and clinical characteristics 
 Healty controls  
(n = 51) 
   Patient with vitamin D 
deficiency (n = 54) 
p-value 
Age (years) 28.8 ± 6.48 27.8 ± 5.54 0.37 
Gender (M/F) 14/37 7/47 0.053 
SBP 115.9 ± 12.5 116.4 ± 10.8 0.33 
DBP 73.9 ± 5.5 73,8 ± 6.7 0.39 
BMI 24.22 ± 3.2 24.13 ± 3.4 0.89 
25(OH)D (nmol/l) 52.47 ± 21.7 15.28 ± 8.3 < 0.001 
Values are mean ± SD; M, male; F, female; SBP, systolic blood pressure; DBP, diastolic 
blood pressure; BMI, body mass index. 
 
 
Electrocardiogram and heart rate variability 
analysis revealed that mean RR, mean HR, SDNN, 
SDANN, SDNNI, RMSDD, and PNN50 in time domain 
parameters did not differ significantly between groups. 
When the QT intervals were compared, only a slight 
but significant proloangation of QTc intervals were 
detected in the control group. However, there was no 
significant difference between two groups in the QT 
intervals. Table 2 summarises the HRV and QT 
parameters in subjects with vitamin D deficiency and 
the control group.  
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Table 2: Heart rate variability parameters and QT analysis in 
patients with vitamin D deficiency and healthy controls 
 
 Healthy Controls 
(n = 51) 
Patient with Vitamin D 
Deficiency (n = 54) 
p-value 
Mean heart rate (beats/min) 89 ± 10.7 88.7 ± 12.1 0.90 
Mean RR 694 ± 93.8 698 ± 100 0.86 
SDNN (ms) 70.8 ± 21.5 66.6 ± 20.4 0.31 
SDANN (ms) 45.1 ± 16.6 38,5 ± 21.4 0.37 
SDNNI (ms) 54.4 ± 17.3 52.3 ± 15.1 0.50 
rMSDD (ms) 25.4 ± 11.3 25.8 ± 11.1 0.86 
pNN50 (%) 7.06 ± 8.6 6.54 ± 7.5 0.52 
QT (ms) 369 ± 33.6 359 ± 27.1 0.07 
QTc (ms) 408 ± 28.3 395 ± 25 0.013 
SDNN, standard deviations of all NN intervals; SDNNI, mean of the standard 
deviations of all NN intervals for all 5-minute segments of the entire recording; SDANN, 
standard deviation of the averages of NN intervals in all 5-minute segments of the entire 
recording; RMSSD, the square root of the mean of the sum of the squares of differences 
between adjacent NN intervals; pNN50, the number of pairs of adjacent NN intervals 
differing by more than 50 ms divided by the total number of all NN interval. 
 
Correlation analysis for HRV parameters in 
vitamin D deficiency group is shown in Table 3. 
Table 3: Correlation coefficients for heart rate variability 
parameters in vitamin D deficiency group 
Standardised coefficients          Beta                         t                           p-value 
SDNN (ms)       0.101  0.32 0.74 
SDANN (ms)      -0.119 -0.60 0.54 
SDNNI (ms)      -0.201 -0.86 0.38 
rMSDD (ms)       0.259  1.34 0.18 
pNN50 (%)      -0.125 -0.77 0.44 
QT (ms)       0.074  0.79 0.42 
QTc (ms)      -0.135 -1.48 0.14 
Abbreviations; see Table 2. 
 
 
Discussion 
 
This study showed that low vitamin D status is 
not associated with diminished HRV parameters in a 
low cardiovascular risk group. A probable explanation 
for the lacking association is that our study focuses on 
younger individuals who were free of any 
cardiovascular disease and risk factors. Furthermore, 
low vitamin D status alone has not any potential to 
initiate lethal arrhythmias, especially ventricular 
fibrillation as assessed by HRV and QT. 
Our results are contrary the study of YJ TAK 
et al., in which they have studied HRV in a population 
with more advanced age and high cardiovascular risk. 
In their study, they have included a very high-risk 
group into the study as compared to our study group. 
We did not find any significant correlation in the HRV 
and QT data between the vitamin D deficiency and 
control groups [19]. HRV shows the effects of 
sympathetic and parasympathetic on the sinus node. 
HRV parameters evaluate the different types of 
autonomic nerve system effects on the heart with sinus 
rhythm. RMSSD and HF show variations in 
parasympathetic effects and LF is an indicator of 
sympathetic activity regulation on the sinus node. 
SDNN and LF show the influenced of both adrenergic 
and cholinergic activities on the sinus node. Any 
changes in all HRV parameters affect SDNN and 
SDNN is decreased in left ventricle systolic 
dysfunction [20]. SDANN, SDNNI, rMSDD and pNN50 
are the other HRV parameters that show cardiac 
autonomic functions and evaluate the sympathetic and 
parasympathetic tones on cardiac functions [21]. 
Vitamin D has direct effects on myocytes. Vitamin D 
also affects cardiac contractility indirectly by calcium 
metabolism and directly via vitamin D receptors [12]. 
Our hypothesis mainly depends on the seasonal 
changes in arrhythmia related deaths in winter times 
and vitamin is a sunlight defendant [22, 23]. So, we 
have chosen the HRV analyses for evaluation of the 
subclinical disturbances that poses the vitamin 
deficient people to malign cardiac arrhythmias. 
Structural and ionic channel remodelling due 
to low vitamin D serum levels may prolong the 
repolarization interval [12]. These changes have been 
shown to cause altered myocardial calcium, 
prolongation of the repolarization interval and cardiac 
action potential over time [11-14]. Furthermore, low 
vitamin D levels also induce oxidative stress, 
vasoconstriction and cardiac hypertrophy. All of these 
mechanisms may also increase myocardial 
susceptibility to fatal cardiac arrhythmias and 
eventually lead to SCD [13, 22, 25]. Previous studies 
showed that seasonal variations in SCD rates are high 
during winter and are lowest in the summer months 
[23, 24]. The synthesis of vitamin D is also dependent 
on the intensity of daylight exposure with peak values 
in the summer and lowest values in winter [26, 27]. 
iAlso, prior studies have demonstrated seasonal 
variation in autonomic tone that may be induced by the 
intensity of daylight exposure and D vitamin status 
[28]. 
A recent study evaluated the association 
between SCD and the combination of low vitamin D 
status and parathyroid hormone (PTH) excess in 
participants who were free of clinical cardiovascular 
disease at baseline. However, the combination of 
vitamin D deficiency and high PTH concentrations did 
not increase the risk of SCD to 2.5 times, while individual 
risk factors, low vitamin D status nor high PTH levels 
were related with SCD events [13]. These associations 
have not been found in populations free of 
cardiovascular disease. Another strength of our study 
was a measurement of vitamin D levels only at a 
single point in time. However, we found no association 
between vitamin D deficiency and cardiac autonomic 
dysfunction using HRV which suggests that the effects 
of vitamin D deficiency on the cardiovascular system 
may not be immediate. 
Limitations: Most important limitation of our 
study is the small sample size. Another issue is the 
absence of 24 or 48-hour Holter ECG monitoring and 
absence of follow-up for developing adverse events. 
In conclusion, we found that there was no 
relationship between HRV variables and the vitamin D 
deficiency in subjects without cardiovascular risk 
factors. Vitamin D deficiency does not alter cardiac 
autonomic functions as assessed by HRV. Further 
studies are needed for evaluation of these findings in 
other cohorts with cardiovascular risk factors. 
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